Efficacy and tolerability of rimonabant in overweight or obese patients with type 2 diabetes: a randomised controlled study

The Hospital Anxiety and Depression Scale

1983 • 42,177 citations

The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection.

1992 • 33,264 citations

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

1985 • 29,733 citations

Summary of the Second Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II)

1993 • 28,274 citations

The MOS 36-ltem Short-Form Health Survey (SF-36)

1992 • 26,794 citations

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)

1998 • 19,638 citations

Reduction in the Incidence of Type 2 Diabetes with Lifestyle Intervention or Metformin

2002 • 18,132 citations

Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) Final Report

2002 • 12,876 citations

Detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III)

2002 • 12,292 citations

Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study

2000 • 8,604 citations

Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group.

1998 • 8,603 citations

Mortality from Coronary Heart Disease in Subjects with Type 2 Diabetes and in Nondiabetic Subjects with and without Prior Myocardial Infarction

1998 • 7,057 citations

The metabolic syndrome

2010 • 6,321 citations

The metabolic syndrome

2005 • 5,005 citations

A sharper Bonferroni procedure for multiple tests of significance

1988 • 4,545 citations

Multifactorial Intervention and Cardiovascular Disease in Patients with Type 2 Diabetes

2003 • 4,328 citations

C-Reactive Protein and Other Circulating Markers of Inflammation in the Prediction of Coronary Heart Disease

2004 • 2,914 citations

Obesity and the risk of myocardial infarction in 27 000 participants from 52 countries: a case-control study

2005 • 2,821 citations

Type 2 diabetes: principles of pathogenesis and therapy

2005 • 2,509 citations

Obesity, Fat Distribution, and Weight Gain as Risk Factors for Clinical Diabetes in Men

1994 • 1,842 citations

Leptin-regulated endocannabinoids are involved in maintaining food intake

2001 • 1,557 citations

Effects of Exenatide (Exendin-4) on Glycemic Control and Weight Over 30 Weeks in Metformin-Treated Patients With Type 2 Diabetes

2005 • 1,541 citations

Effects of the cannabinoid-1 receptor blocker rimonabant on weight reduction and cardiovascular risk factors in overweight patients: 1-year experience from the RIO-Europe study

2005 • 1,509 citations

NCEP-Defined Metabolic Syndrome, Diabetes, and Prevalence of Coronary Heart Disease Among NHANES III Participants Age 50 Years and Older

2003 • 1,462 citations

Effects of Rimonabant on Metabolic Risk Factors in Overweight Patients with Dyslipidemia

2005 • 1,380 citations

Coronary heart disease

1966 • 1,258 citations

Management of Hyperglycemia in Type 2 Diabetes: A Consensus Algorithm for the Initiation and Adjustment of Therapy

2006 • 1,238 citations

Effect of Rimonabant, a Cannabinoid-1 Receptor Blocker, on Weight and Cardiometabolic Risk Factors in Overweight or Obese Patients

2006 • 1,226 citations

The endogenous cannabinoid system affects energy balance via central orexigenic drive and peripheral lipogenesis

2003 • 1,123 citations

Global Guideline for Type 2 Diabetes

2014 • 1,033 citations

Adiponectin: More Than Just Another Fat Cell Hormone?

2003 • 1,004 citations

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

2005 • 976 citations

Clinical Implications of Obesity With Specific Focus on Cardiovascular Disease

2004 • 939 citations

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity

2005 • 895 citations

Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study

2006 • 737 citations

Regulation, Function, and Dysregulation of Endocannabinoids in Models of Adipose and β-Pancreatic Cells and in Obesity and Hyperglycemia

2006 • 632 citations

Development of a Brief Measure to Assess Quality of Life in Obesity

2001 • 614 citations

Cannabinoid physiology and pharmacology: 30 years of progress

2004 • 606 citations

The Cannabinoid CB₁Receptor Antagonist SR141716 Increases Acrp30 mRNA Expression in Adipose Tissue of Obese fa/fa Rats and in Cultured Adipocyte Cells

2003 • 604 citations

Anti-obesity effect of SR141716, a CB1 receptor antagonist, in diet-induced obese mice

2003 • 574 citations

Intentional weight loss and mortality among overweight individuals with diabetes.

2000 • 559 citations

Clinical Practice Recommendations

2011 • 554 citations

Long-term Effects of Modest Weight Loss in Type II Diabetic Patients

1987 • 475 citations

Criteria for the Validation of Surrogate Endpoints in Randomized Experiments

1998 • 416 citations

Management of hyperglycaemia in type 2 diabetes: a consensus algorithm for the initiation and adjustment of therapy

2006 • 408 citations

Adiponectin and Coronary Heart Disease

2006 • 402 citations

Long-term pharmacotherapy for overweight and obesity: a systematic review and meta-analysis of randomized controlled trials

2003 • 342 citations

Psychometric evaluation of the impact of weight on quality of life-lite questionnaire (IWQOL-lite) in a community sample.

2002 • 336 citations

Effects of the cannabinoid CB1 receptor antagonist SR141716 on oxygen consumption and soleus muscle glucose uptake in Lepob/Lepob mice

2004 • 316 citations

THIRD NATIONAL HEALTH AND NUTRITION EXAMINATION SURVEY (NHANES III); NATIONAL CHOLESTEROL EDUCATION PROGRAM (NCEP). NCEP-DEFI NED METABOLIC SYNDROME, DIABETES, AND PREVALENCE OF CORONARY HEART DISEASE AMONG NHANES III PARTICIPANTS AGE 50 YEARS AND OLDER

2003 • 302 citations

The anti‐obesity effect of rimonabant is associated with an improved serum lipid profile

2004 • 203 citations

Type II Diabetic Subjects Lose Less Weight Than Their Overweight Nondiabetic Spouses

1987 • 194 citations

Modern statistical methods for handling missing repeated measurements in obesity trial data: beyond LOCF

2003 • 178 citations

Efficacy of Pharmacotherapy for Weight Loss in Adults With Type 2 Diabetes Mellitus

2004 • 150 citations

Techniques for the experimental measurement of human eating behaviour and food intake: a practical guide.

1995 • 140 citations

Comparison of Obese NIDDM and Nondiabetic Women: Short‐ and Long‐Term Weight Loss

1995 • 116 citations

Current Management Strategies for Coexisting Diabetes Mellitus and Obesity

2003 • 94 citations

Comparison of imputation and modelling methods in the analysis of a physical activity trial with missing outcomes

2004 • 92 citations